Cargando…
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
Identification of the different elements intervening at the tumor microenvironment seems key to explain clinical evolution in several tumor types. In this study, a set of immune biomarkers (myeloid derived suppressor cells, regulatory T cells, and OX40 + and PD-1 + T lymphocytes counts) in periphera...
Autores principales: | Palazón-Carrión, Natalia, Jiménez-Cortegana, Carlos, Sánchez-León, M. Luisa, Henao-Carrasco, Fernando, Nogales-Fernández, Esteban, Chiesa, Massimo, Caballero, Rosalía, Rojo, Federico, Nieto-García, María-Adoración, Sánchez-Margalet, Víctor, de la Cruz-Merino, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277895/ https://www.ncbi.nlm.nih.gov/pubmed/34257359 http://dx.doi.org/10.1038/s41598-021-93838-w |
Ejemplares similares
-
Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
por: Palazón‑Carrión, Natalia, et al.
Publicado: (2021) -
Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy
por: Sánchez-Margalet, Víctor, et al.
Publicado: (2019) -
Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021) -
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
por: de la Cruz-Merino, Luis, et al.
Publicado: (2021) -
Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics
por: García-Domínguez, Daniel J., et al.
Publicado: (2022)